HIGHLIGHTS
- who: Huayuan Liang from the Sun Yat-sen University Cancer Center (SYSUCC), China have published the research work: Prognostic characteristics and clinical response to immunotherapy targeting programmed cell death 1 for patients with advanced gastric cancer with liver metastases, in the Journal: (JOURNAL)
- what: In the population , the authors demonstrate that the presence of peritoneal metastases is an independent risk factor associated with poor prognosis in gastric cancer patients, extremely worse accompanied with liver metastases. The study demonstrates that immunotherapy combined with anti-HER2 treatment could significantly improve survival benefits in gastric cancer patients with . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.